돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 478211생성일: 2026년 10월 26일

Methyltryptamine → (2-Indol-3-ylethyl)methyl(3-piperidylpropyl)amine Hydrochloride

https://huagongshe.com/reaction/478211

반응식

참여 물질

역할이름HCID투입량
반응물MethyltryptamineHCID 6088—
반응물N-(3-chloropropyl)piperidine hydrochlorideHCID 79624—
반응물1-(3-Chloropropyl)-3-(4-methoxyphenyl)piperidine hydrochlorideHCID 18001209—
생성물(2-Indol-3-ylethyl)methyl(3-piperidylpropyl)amine HydrochlorideHCID 70038108—

반응 단계

Using 3-(2-methylaminoethyl)indole (123 mg, 0.70 mmol) and 1-(3-chloropropyl)piperidine hydrochloride (198 mg, 1.0 mmol) instead of 4-(3-indolyl)piperidine and 1-(3-chloropropyl)-3-(4-methoxyphenyl)piperidine hydrochloride respectively, reaction and concentration were carried out in the same procedure as Example 2. The resulting crude product was purified by column chromatography on a silica gel (silica gel NH-DM 1020 produced by Fuji Silysia Chemical Ltd., eluent; hexane:ethyl acetate=1:1) to afford a free form (166 mg) of the title compound as a pale yellow viscous oil. After adding hydrochloric acid/methanol to a solution of the free form in methanol, the mixture was concentrated and was then reprecipitated with methanol/ether to afford the title compound (167 mg, yield: 64%) as a pale yellow crystalline powder.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06642228B1
출처 데이터셋uspto-grants-2003_11
ORD IDord-56eef1aae78645eda9dc05bd421b5a5b
출처 메모uspto-grants-2003_11